Latest Breaking News On - Paris based institut curie - Page 1 : comparemela.com

Biomunex Pharmaceuticals, a French company focused on the discovery and development of bi- and multi-specific antibodies, sees its BiXAb5 project receive nearly €3m (US$3.5m) in the form of a grant from the French government.

Pierre emmanuel gerardInstitut curieParis based institut curieOnward therapeuticsMarkets amp regulationsCell amp gene therapiesSolid tumorT cell